{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:03:25Z","timestamp":1788469405447,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005979","name":"Lustgarten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001767","name":"National Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35-CA197743"],"award-info":[{"award-number":["R35-CA197743"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-0219"],"award-info":[{"award-number":["W81XWH-16-0219"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.expneurol.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T12:18:21Z","timestamp":1505132301000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PB","title":["Anti-VEGF treatment improves neurological function in tumors of the nervous system"],"prefix":"10.1016","volume":"299","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino B.","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-183X","authenticated-orcid":false,"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2017.09.008_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0925-4773(01)00471-3","article-title":"Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization","volume":"108","author":"Acker","year":"2001","journal-title":"Mech. Dev."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene discovery in amyotrophic lateral sclerosis: implications for clinical management","volume":"13","author":"Al-Chalabi","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrneurol.2011.82","article-title":"Emerging therapeutic targets in schwannomas and other merlin-deficient tumors","volume":"7","author":"Ammoun","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0020","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/en.2010-1290","article-title":"17Beta-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus","volume":"152","author":"Barouk","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0025","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1158\/1078-0432.CCR-10-1868","article-title":"Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells","volume":"17","author":"von Baumgarten","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0030","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/cercor\/bhm190","article-title":"Effects of visual experience on vascular endothelial growth factor expression during the postnatal development of the rat visual cortex","volume":"18","author":"Bengoetxea","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0035","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2015.64.3817","article-title":"Efficacy and biomarker study of bevacizumab for hearing loss resulting from neurofibromatosis type 2-associated vestibular schwannomas","volume":"34","author":"Blakeley","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0040","first-page":"2021","article-title":"Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats","volume":"43","author":"Bocker-Meffert","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/aja.1002040303","article-title":"Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development","volume":"204","author":"Breier","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0050","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/00016480310005101","article-title":"Expression of angiogenic growth factors in acoustic neurinoma","volume":"123","author":"Brieger","year":"2003","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0055","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1172\/JCI8218","article-title":"VEGF antagonism reduces edema formation and tissue damage after ischemia\/reperfusion injury in the mouse brain","volume":"104","author":"van Bruggen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0060","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1101\/gad.615311","article-title":"Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis","volume":"25","author":"Calvo","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrg1158","article-title":"Blood vessels and nerves: common signals, pathways and diseases","volume":"4","author":"Carmeliet","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0080","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00005537-200312000-00014","article-title":"Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate","volume":"113","author":"Caye-Thomasen","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0090","first-page":"97","article-title":"Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis","volume":"237","author":"Dvorak","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1067\/mcp.2002.126179","article-title":"A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans","volume":"72","author":"Eppler","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0100","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q. J. Med."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2011.03.088","article-title":"Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease","volume":"496","author":"Falk","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.2000.tb06352.x","article-title":"Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link?","volume":"903","author":"Farkas","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0115","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1523-1755.1999.00610.x","article-title":"Role of vascular endothelial growth factor in the regulation of angiogenesis","volume":"56","author":"Ferrara","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0130","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0135","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1200\/JCO.2008.19.8721","article-title":"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma","volume":"27","author":"Friedman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0140","doi-asserted-by":"crossref","first-page":"14676","DOI":"10.1073\/pnas.1512570112","article-title":"Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrclinonc.2009.14","article-title":"VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer","volume":"6","author":"Gerstner","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0160","first-page":"1592","article-title":"Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function","volume":"59","author":"Grunstein","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0165","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1073\/pnas.1407227111","article-title":"VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions","volume":"111","author":"Guaiquil","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0170","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archneur.63.12.1681","article-title":"Neuroprotection in the peripheral nervous system: rationale for more effective therapies","volume":"63","author":"Hoke","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0175","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1073\/pnas.97.18.10242","article-title":"Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia","volume":"97","author":"Jin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(01)00154-3","article-title":"Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor","volume":"108","author":"Jin","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0185","doi-asserted-by":"crossref","first-page":"11946","DOI":"10.1073\/pnas.182296499","article-title":"Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0169-328X(98)00190-9","article-title":"Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia","volume":"62","author":"Kalaria","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0195","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2008.19.9356","article-title":"Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice","volume":"27","author":"Kamoun","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0200","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3171\/2008.12.JNS08611","article-title":"Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma","volume":"111","author":"Kano","year":"2009","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0205","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","article-title":"Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0210","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbadis.2006.04.005","article-title":"VEGF at the neurovascular interface: therapeutic implications for motor neuron disease","volume":"1762","author":"Lambrechts","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0220","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nn1646","article-title":"VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain","volume":"9","author":"Le Bras","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11060-016-2091-3","article-title":"Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1","volume":"128","author":"Lee","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0230","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00005072-199809000-00009","article-title":"Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat","volume":"57","author":"Lennmyr","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1227\/01.NEU.0000349931.61771.52","article-title":"Recombinant adeno-associated virus serotype 1-vascular endothelial growth factor promotes neurogenesis and neuromigration in the subventricular zone and rescues neuronal function in ischemic rats","volume":"65","author":"Li","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0240","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ajpath.2010.12.001","article-title":"IL-17 and VEGF are necessary for efficient corneal nerve regeneration","volume":"178","author":"Li","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1242\/dev.039636","article-title":"VEGF is required for dendritogenesis of newly born olfactory bulb interneurons","volume":"137","author":"Licht","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0250","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulations of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2017.09.008_bb0255","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/sj.ijir.3901214","article-title":"Growth factor therapy and neuronal nitric oxide synthase","volume":"16","author":"Lin","year":"2004","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0260","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1464-410X.2003.04439.x","article-title":"Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia","volume":"92","author":"Lin","year":"2003","journal-title":"BJU Int."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0265","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0896-6273(02)00722-5","article-title":"Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain","volume":"34","author":"Louissaint","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0270","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.2014.55.9575","article-title":"Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma","volume":"33","author":"Lu-Emerson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0275","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2353\/ajpath.2006.050834","article-title":"Vascular endothelial growth factor localization in the adult","volume":"168","author":"Maharaj","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0280","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ijrobp.2009.12.010","article-title":"Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation","volume":"76","author":"McGee","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0285","first-page":"323","article-title":"Vascular endothelial growth factor promotes peripheral nerve regeneration after sciatic nerve transection in rat","volume":"16","author":"Mohammadi","year":"2013","journal-title":"Chin. J. Traumatol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0295","first-page":"4185","volume":"58","author":"Oku","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0305","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.mcn.2007.12.005","article-title":"Myelination in mouse dorsal root ganglion\/Schwann cell cocultures","volume":"37","author":"Paivalainen","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0310","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3","article-title":"Vascular niche for adult hippocampal neurogenesis","volume":"425","author":"Palmer","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0315","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1096\/fj.12-225185","article-title":"Vascular endothelial growth factor promotes anatomical and functional recovery of injured peripheral nerves in the avascular cornea","volume":"27","author":"Pan","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/02688697.2013.815323","article-title":"The changing face of acoustic neuroma management in the USA: analysis of the 1998 and 2008 patient surveys from the acoustic neuroma association","volume":"28","author":"Patel","year":"2014","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0325","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2990.2011.01159.x","article-title":"Enhancement of sciatic nerve regeneration after vascular endothelial growth factor (VEGF) gene therapy","volume":"37","author":"Pereira Lopes","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0330","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00005072-199906000-00010","article-title":"Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct","volume":"58","author":"Plate","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0335","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJMoa0902579","article-title":"Hearing improvement after bevacizumab in patients with neurofibromatosis type 2","volume":"361","author":"Plotkin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0340","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","article-title":"Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients","volume":"33","author":"Plotkin","year":"2012","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0345","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MAO.0000000000000239","article-title":"Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients","volume":"35","author":"Plotkin","year":"2014","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0350","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00401-007-0228-3","article-title":"Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system","volume":"113","author":"Raab","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0355","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz de Almodovar","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0360","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1523\/JNEUROSCI.0477-10.2010","article-title":"Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1","volume":"30","author":"Ruiz de Almodovar","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-3639.2004.tb00060.x","article-title":"Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor","volume":"14","author":"Schanzer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0370","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/74664","article-title":"Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy","volume":"6","author":"Schratzberger","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0375","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/mt.2014.76","article-title":"Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF\/GDNF signaling","volume":"22","author":"Shvartsman","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2012.07.006","article-title":"PEGylated-PLGA microparticles containing VEGF for long term drug delivery","volume":"440","author":"Simon-Yarza","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0385","first-page":"53","article-title":"Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model","volume":"28","author":"Son","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0390","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1523\/JNEUROSCI.19-14-05731.1999","article-title":"Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system","volume":"19","author":"Sondell","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0395","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3171\/jns.1999.90.5.0815","article-title":"Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2","volume":"90","author":"Subach","year":"1999","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0400","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI200317977","article-title":"VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia","volume":"111","author":"Sun","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0405","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ydbio.2005.10.016","article-title":"Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration","volume":"289","author":"Sun","year":"2006","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0410","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/lary.21908","article-title":"Gamma knife radiosurgery for vestibular schwannomas: identification of predictors for continued tumor growth and the influence of documented tumor growth preceding radiation treatment","volume":"121","author":"Timmer","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0415","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/0008-5472.CAN-10-2602","article-title":"Glioblastoma recurrence after cediranib therapy in patients: lack of \u201crebound\u201d revascularization as mode of escape","volume":"71","author":"di Tomaso","year":"2011","journal-title":"Cancer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2017.09.008_bb0420","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00002093-200000001-00012","article-title":"Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease","volume":"14","author":"de la Torre","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0425","first-page":"6248","article-title":"Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha\u2192hypoxia response element\u2192VEGF cascade differentially regulates vascular response and growth rate in tumors","volume":"60","author":"Tsuzuki","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0430","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2004.06.004","article-title":"Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration","volume":"17","author":"Van Den Bosch","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0435","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1016\/j.ejca.2009.08.004","article-title":"Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma","volume":"45","author":"Verhoeff","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0440","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2007.12.2440","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme","volume":"25","author":"Vredenburgh","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0445","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/030089161410000212","article-title":"Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature","volume":"100","author":"Wagner","year":"2014","journal-title":"Tumori"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.expneurol.2009.05.037","article-title":"The nerve regenerative microenvironment: early behavior and partnership of axons and Schwann cells","volume":"223","author":"Webber","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0455","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.expneurol.2017.09.008_bb0460","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1523\/JNEUROSCI.5527-08.2009","article-title":"VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo","volume":"29","author":"Wittko","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0465","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1074\/jbc.M108347200","article-title":"Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1\/2 MAPK signaling pathway: mechanism of low pH-induced VEGF","volume":"277","author":"Xu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0470","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1167\/iovs.07-1418","article-title":"Vascular endothelial growth factor mediates corneal nerve repair","volume":"49","author":"Yu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0475","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.93.25.14765","article-title":"Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor\/vascular permeability factor antibody","volume":"93","author":"Yuan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.09.008_bb0480","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI9369","article-title":"VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain","volume":"106","author":"Zhang","year":"2000","journal-title":"J. Clin. Invest."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617302364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617302364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:48:26Z","timestamp":1762148906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617302364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":96,"alternative-id":["S0014488617302364"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.09.008","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-VEGF treatment improves neurological function in tumors of the nervous system","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}